
Gwaro iri rakazara rinoongorora fungidziro yerenal cell carcinoma (RCC) kuChina uye rinoratidza zvipatara zvinotungamira zvinonyanya kurapwa kwayo. Isu tinoongorora muzvinhu zvinopesvedzera kufungidzira, marapirwo aripo, uye zviwanikwa zvevarwere nemhuri dzavo. Kunzwisisa zvinhu izvi kwakakosha pakufamba rwendo urwu rwakaoma.
The prognosis of China renal cell carcinoma inosiyana zvakanyanya zvichienderana nezvikonzero zvakawanda. Izvi zvinosanganisira danho regomarara pakuongororwa, hutano hwemurwere hwese, rudzi uye giredhi reRCC, uye kushanda kwekurapa kwakasarudzwa. Kuonekwa kwekutanga uye kurapwa nekukurumidza kwakakosha pakuvandudza mhedzisiro. Zvimwe zvikonzero zvemajini zvinogonawo kukanganisa kufungidzira. Kuwanikwa kune zvivakwa zvekurapa zvepamberi uye vane ruzivo oncologists kunoitawo basa rakakosha.
Kurongeka kwakaringana uye kugadzika kweRCC kwakakosha pakuona chirongwa chakanyanya chekurapa uye kufanotaura kufungidzira. Mataging masisitimu, akadai seTNM staging system, anoshandiswa kurongedza huwandu hwekupararira kwegomarara. Giredhi rinoratidza hukasha hwemabundu masero. Varwere vanofanirwa kukurukura izvi zvikamu zvakadzama nanachiremba vavo kuti vanzwisise zvizere fungidziro yavo yega.
Kuvhiya kazhinji ndiko kurapwa kwekutanga kweRCC yemuno. Mhando yekuvhiyiwa inoenderana nehukuru uye nzvimbo yebundu. Sarudzo zvinosanganisira chikamu nephrectomy (kubviswa kwebundu chete) uye radical nephrectomy (kubviswa kweitsvo yese). Minimally invasive maitiro ekuvhiya ari kuwedzera kushandiswa kuderedza kupora nguva uye matambudziko. Kubudirira kwekupindira kwekuvhiya kwakakura zvakanyanya kana RCC ichiongororwa pamatanho ekutanga.
Kurapa kwakanangwa kwakagadzirirwa kurwisa chaiwo mamorekuru anobatanidzwa mukukura nekupararira kwekenza maseru. Mishonga iyi inogona kushanda zvakanyanya kune mamwe marudzi eRCC, kunyanya ayo ane genetic mutations. Mishonga yakawanda yakanangwa inotenderwa kushandiswa muChina, uye mitsva inogara ichigadzirwa. Wako oncologist achaona kana kurapa kwakanangwa kwakakodzera mamiriro ako chaiwo.
Immunotherapy inoshandisa simba remuviri wega immune system kurwisa cancer. Iyi nzira inonyanya kuvimbisa kune advanced RCC. Mazhinji immunotherapy zvinodhaka, kusanganisira checkpoint inhibitors, vakaratidza kubudirira kukuru mukuvandudza kufungidzira uye kuwedzera kupona kune varwere vane metastatic RCC. Miedzo yemakiriniki inowanzoitwa muChina ichiongorora ma immunotherapies matsva.
Zvipatara zvinoverengeka muChina zvakazvimisikidza senzvimbo dzehunyanzvi hwekuongororwa uye kurapwa kweRCC. Zvipatara izvi zvinowanzo kuwana tekinoroji yazvino, vane ruzivo rwe oncologists, uye masevhisi akazara ekutsigira varwere nemhuri dzavo. Izvo zvakakosha kuti utsvage uye usarudze chipatara chinoenderana nezvido zvako uye zvaunofarira.
Kunyange zvazvo chinyorwa ichi chisingapi runyoro rwakakwana, funga nezvekutsvaga zvipatara zvinozivikanwa nemadhipatimendi avo eoncology uye hunyanzvi chaihwo murenal cell carcinoma. Kubata zvipatara zvakananga uye kubvunza nezvezvirongwa zvavo zveRCC uye vanachiremba vane hunyanzvi zvinokurudzirwa.
Kune avo vari kutsvaga rubatsiro rwakanyanya, munogona kuda kuongorora zviwanikwa zvinopihwa pa Shandong Baofa Cancer Research Institute. Vakazvipira kupa rubatsiro rwepamusoro-soro rwegomarara.
Kuonekwa kwekutanga kunoita basa rakakosha mukuvandudza fungidziro ye China renal cell carcinoma. Kugara uchiongorora, kunyanya kana uine njodzi dzeRCC, kwakakosha. Kuchengeta mararamiro ane hutano, kusanganisira kudya kwakakwana, kurovedza muviri nguva dzose, uye kudzivisa kusvuta, zvinogonawo kuderedza dambudziko rako rekuita RCC.
Ruzivo urwu rwakaitirwa zvinangwa zvekudzidzisa chete uye harufanirwe kutorwa sezano rekurapa. Gara uchibvunzurudza nenyanzvi yehutano yehutano kuti iongororwe uye kurapwa kwechero mamiriro ekurapa. Mafungiro uye nzira dzekurapa dzeRCC dzinogona kusiyana zvakanyanya zvichienderana nechinhu chimwe nechimwe.
parutivi>
body>